Cargando…

Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China

BACKGROUND: Hereditary transthyretin amyloidosis (hATTR) is a progressive and fatal disease with heterogenous clinical presentations, limited diagnosis and poor prognosis. This retrospective analysis study aimed to report the genotypes and phenotypes of herediary transthyretin amyloidosis (hATTR) in...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Xinyue, Tian, Zhuang, Guan, Hongzhi, Zhang, Shuyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438301/
https://www.ncbi.nlm.nih.gov/pubmed/36056432
http://dx.doi.org/10.1186/s13023-022-02481-9
_version_ 1784781798847283200
author He, Xinyue
Tian, Zhuang
Guan, Hongzhi
Zhang, Shuyang
author_facet He, Xinyue
Tian, Zhuang
Guan, Hongzhi
Zhang, Shuyang
author_sort He, Xinyue
collection PubMed
description BACKGROUND: Hereditary transthyretin amyloidosis (hATTR) is a progressive and fatal disease with heterogenous clinical presentations, limited diagnosis and poor prognosis. This retrospective analysis study aimed to report the genotypes and phenotypes of herediary transthyretin amyloidosis (hATTR) in Chinese through a systematic review of published literature. METHODS: The systematic review included structured searches of peer-reviewed literature published from 2007 to 2020 of following online reference databases: PubMed, Web of Science and the literature database in China. Extracted data included sample size, personal information (sex, age, natural course, family history), mutation type, clinical milestones and reason of death. RESULTS: We described 126 Chinese patients with hereditary transthyretin amyloidosis identified through a systematic review of 30 studies. The most common genotype in the Chinese population was Gly83Arg (25, 19.8%), which most likely presented visual and neurological abnormalities without reported death. The second and third most common genotypes were Val30Met (20, 15.9%) and Val30Ala (10, 7.9%). Peripheral neurological manifestations (91, 72%) were dominant in 126 patients. The followed manifestation was autonomic neurological abnormalities (73, 58%). Half of the cases were reported to have visual disorders, and nearly one-third of the cases presented cardiac abnormalities. Among all 126 reported patients, 46.03% were classified as neurological type, 30.16% as mixed type and only 2.38% as cardiac type. In addition. Chinese patients were mostly early onset, with age of onset at 41.8 (SD: 8.9) years, and the median time from onset to death was 7.5 [IQR: 5.3] years. Patients with cardiac involvement had a shorter survival duration (log Rank (Mantel-Cox), χ(2) = 26.885, P < 0.001). CONCLUSIONS: This study focused on 126 Chinese hATTR patients obtained from a literature review. A total of 26 kinds of TTR mutations were found and the most common one was Gly83Arg. As for phenotype, 46.03% were classified as neurological type, 30.16% as mixed type and only 2.38% as cardiac type. Chinese hATTR patients were mostly early onset (AO 41.8 years), and the median time from onset to death was 7.5 years. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-022-02481-9.
format Online
Article
Text
id pubmed-9438301
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-94383012022-09-03 Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China He, Xinyue Tian, Zhuang Guan, Hongzhi Zhang, Shuyang Orphanet J Rare Dis Research BACKGROUND: Hereditary transthyretin amyloidosis (hATTR) is a progressive and fatal disease with heterogenous clinical presentations, limited diagnosis and poor prognosis. This retrospective analysis study aimed to report the genotypes and phenotypes of herediary transthyretin amyloidosis (hATTR) in Chinese through a systematic review of published literature. METHODS: The systematic review included structured searches of peer-reviewed literature published from 2007 to 2020 of following online reference databases: PubMed, Web of Science and the literature database in China. Extracted data included sample size, personal information (sex, age, natural course, family history), mutation type, clinical milestones and reason of death. RESULTS: We described 126 Chinese patients with hereditary transthyretin amyloidosis identified through a systematic review of 30 studies. The most common genotype in the Chinese population was Gly83Arg (25, 19.8%), which most likely presented visual and neurological abnormalities without reported death. The second and third most common genotypes were Val30Met (20, 15.9%) and Val30Ala (10, 7.9%). Peripheral neurological manifestations (91, 72%) were dominant in 126 patients. The followed manifestation was autonomic neurological abnormalities (73, 58%). Half of the cases were reported to have visual disorders, and nearly one-third of the cases presented cardiac abnormalities. Among all 126 reported patients, 46.03% were classified as neurological type, 30.16% as mixed type and only 2.38% as cardiac type. In addition. Chinese patients were mostly early onset, with age of onset at 41.8 (SD: 8.9) years, and the median time from onset to death was 7.5 [IQR: 5.3] years. Patients with cardiac involvement had a shorter survival duration (log Rank (Mantel-Cox), χ(2) = 26.885, P < 0.001). CONCLUSIONS: This study focused on 126 Chinese hATTR patients obtained from a literature review. A total of 26 kinds of TTR mutations were found and the most common one was Gly83Arg. As for phenotype, 46.03% were classified as neurological type, 30.16% as mixed type and only 2.38% as cardiac type. Chinese hATTR patients were mostly early onset (AO 41.8 years), and the median time from onset to death was 7.5 years. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-022-02481-9. BioMed Central 2022-09-02 /pmc/articles/PMC9438301/ /pubmed/36056432 http://dx.doi.org/10.1186/s13023-022-02481-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
He, Xinyue
Tian, Zhuang
Guan, Hongzhi
Zhang, Shuyang
Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China
title Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China
title_full Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China
title_fullStr Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China
title_full_unstemmed Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China
title_short Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China
title_sort clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in china
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438301/
https://www.ncbi.nlm.nih.gov/pubmed/36056432
http://dx.doi.org/10.1186/s13023-022-02481-9
work_keys_str_mv AT hexinyue clinicalphenotypesandgeneticfeaturesofhereditarytransthyretinamyloidosispatientsinchina
AT tianzhuang clinicalphenotypesandgeneticfeaturesofhereditarytransthyretinamyloidosispatientsinchina
AT guanhongzhi clinicalphenotypesandgeneticfeaturesofhereditarytransthyretinamyloidosispatientsinchina
AT zhangshuyang clinicalphenotypesandgeneticfeaturesofhereditarytransthyretinamyloidosispatientsinchina